Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elina Zorde-Khvalevsky

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Immunotargets and Therapy|June 18, 2026
Irinotecan Modulates Immune Checkpoints in NeuroblastomaTom Lapidus, Elina Zorde-Khvalevsky, Alaa Jolani, et al.
Oncotarget|September 30, 2015
Multistep, effective drug distribution within solid tumorsAmotz Shemi, Elina Zorde Khvalevsky, Rachel Malka Gabai, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 24, 2020
Moderate hyperthermic heating encountered during thermal ablation increases tumor cell activityAurelia Markezana, Muneeb Ahmed, Gaurav Kumar, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 22, 2021
Incomplete thermal ablation of tumors promotes increased tumorigenesisAurelia Markezana, S Nahum Goldberg, Gaurav Kumar, et al.
Hepatology (Baltimore, Md.)|May 15, 2009
Toll-like receptor 3 signaling attenuates liver regenerationElina Zorde-Khvalevsky, Rinat Abramovitch, Hila Barash, et al.
Bone Marrow Transplantation|May 10, 2022
Short treatment of peripheral blood cells product with Fas ligand using closed automated cell processing system significantly reduces immune cell reactivity of the graft in vitro and in vivoGalina Rodionov, Michal Rosenzwaig, Michal Schrift Tzadok, et al.
Toxicologic Pathology|May 6, 2016
Preclinical Safety Evaluation in Rats of a Polymeric Matrix Containing an siRNA Drug Used as a Local and Prolonged Delivery System for Pancreatic Cancer TherapyYuval Ramot, Shay Rotkopf, Rachel Malka Gabai, et al.
Hepatology (Baltimore, Md.)|June 16, 2016
The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitryAlina Simerzin, Elina Zorde-Khvalevsky, Mila Rivkin, et al.
Scientific Reports|September 28, 2023
Fibroblast growth factors induce hepatic tumorigenesis post radiofrequency ablationAurelia Markezana, Mor Paldor, Haixing Liao, et al.
Gastroenterology|August 2, 2016
Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-Derived Erythropoietin and AnemiaMila Rivkin, Alina Simerzin, Elina Zorde-Khvalevsky, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Immunotargets and Therapy|June 18, 2026
Irinotecan Modulates Immune Checkpoints in NeuroblastomaTom Lapidus, Elina Zorde-Khvalevsky, Alaa Jolani, et al.
Oncotarget|September 30, 2015
Multistep, effective drug distribution within solid tumorsAmotz Shemi, Elina Zorde Khvalevsky, Rachel Malka Gabai, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 24, 2020
Moderate hyperthermic heating encountered during thermal ablation increases tumor cell activityAurelia Markezana, Muneeb Ahmed, Gaurav Kumar, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 22, 2021
Incomplete thermal ablation of tumors promotes increased tumorigenesisAurelia Markezana, S Nahum Goldberg, Gaurav Kumar, et al.
Hepatology (Baltimore, Md.)|May 15, 2009
Toll-like receptor 3 signaling attenuates liver regenerationElina Zorde-Khvalevsky, Rinat Abramovitch, Hila Barash, et al.
Bone Marrow Transplantation|May 10, 2022
Short treatment of peripheral blood cells product with Fas ligand using closed automated cell processing system significantly reduces immune cell reactivity of the graft in vitro and in vivoGalina Rodionov, Michal Rosenzwaig, Michal Schrift Tzadok, et al.
Toxicologic Pathology|May 6, 2016
Preclinical Safety Evaluation in Rats of a Polymeric Matrix Containing an siRNA Drug Used as a Local and Prolonged Delivery System for Pancreatic Cancer TherapyYuval Ramot, Shay Rotkopf, Rachel Malka Gabai, et al.
Hepatology (Baltimore, Md.)|June 16, 2016
The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitryAlina Simerzin, Elina Zorde-Khvalevsky, Mila Rivkin, et al.
Scientific Reports|September 28, 2023
Fibroblast growth factors induce hepatic tumorigenesis post radiofrequency ablationAurelia Markezana, Mor Paldor, Haixing Liao, et al.
Gastroenterology|August 2, 2016
Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-Derived Erythropoietin and AnemiaMila Rivkin, Alina Simerzin, Elina Zorde-Khvalevsky, et al.
Pageof 2